Trial Profile
Clinical Trials Insight: 700042754
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 24 Mar 2009
Price :
$35
*
At a glance
- Drugs MVA BN HER2 (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Sponsors BN ImmunoTherapeutics
- 24 Mar 2009 New trial record.